Involved in the biotechnology industry now or want to be in the future? You should register for the ISPE 2017 Annual Meeting & Expo. This year’s event takes place in sunny San Diego, California from 29 October through 1 November.
Sessions will address groundbreaking new technologies, like antibody drug conjugates, oligonucleotide synthesis, and continuous processing to continuous improvements topics like driving efficiencies and plant utilization to maximize production in existing facilities. The event has over 20 presentations focused on elements important to biotechnology. This is not a surprise as even many large traditional pharma firms are investing significantly in development of biologic products.
A stand-out bio session at the ISPE 2017 Annual Meeting & Expo is “Amgen Singapore Next Generation Manufacturing”, taking place Monday, 30 October, 1345–1515. You will have the opportunity to hear about the 10-year process Amgen went thru to evolve their biotechnology manufacturing platform from large scale stainless steel processing to a next generation all disposable single-use manufacturing facility in Singapore.
Are we at a point where we can provide adaptive mobile Biopharma production suites? Do platform processes allow for (and are we ready for) ‘off-the-shelf’ predesigned biologics facilities? We have a full education agenda with biotechnology sessions that will answer this and more.
Explore the ISPE 2017 Annual Meeting & Expo website to see what other bio-specific advantages are awaiting you in San Diego!
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...